Switch to:
More From Other Websites
Most Big Cap 20 Stocks Near Entries, But Risks Exist Sep 22 2014
Gilead's (GILD) Zydelig Gets EU Clearance for Blood Cancer Sep 22 2014
Zacks Rank #1 Additions for Tuesday Sep 16 2014
Biogen/AbbVie Report Positive Data on MS Drug Zinbryta Sep 15 2014
Nasdaq Falls Hard, But Apple Resilient On iPhone Orders Sep 15 2014
3 Stocks Underperforming Today In The Drugs Industry Sep 15 2014
Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers Sep 13 2014
Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada Sep 12 2014
Biogen Reports Positive Two-Year Data on MS Drug Plegridy Sep 12 2014
Detailed Results from Biogen Idec and AbbVie’s Pivotal Phase 3 Decide Study Further Define the... Sep 12 2014
Stocks Show Modest Losses; Biotechs Pressured Again Sep 11 2014
Short Sellers Remain Vigilant Against Biotechs Sep 11 2014
Biogen Idec, Inc. Suddenly Struggling To Keep Up With The Biotech Joneses Sep 11 2014
New Data from ENDORSE Show Positive Results Continued over Five Years with TECFIDERA® (Dimethyl... Sep 11 2014
PLEGRIDY™ (Peginterferon Beta-1a) Two-Year Data Confirm Maintenance of Efficacy and Safety in... Sep 11 2014
Stocks Turn Higher After Soft Start; U.S. Silica Jumps Sep 10 2014
Receptos MS Drug Yields More Good Data; Stock Jumps Sep 10 2014
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval Sep 10 2014
New International Survey Finds MS Patients and Neurologists View Communication Positively, Yet... Sep 10 2014
3 Stocks Pushing The Drugs Industry Lower Sep 09 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK